Researchers are closer to analyze how new class of antibiotics approved recently help in blocking cancer causing proteins.
‘Thiazole’ is newly approved drug to fight against FoxM1, one of the most over-produced cancer causing protein.
Researchers believe that FoxM1 plays an important role in producing cancerous cells and may present a promising target for further anti-cancer treatments.
It was also found that thiazoles may inhibit a molecular complex called proteasomes that disposes old proteins marked for destruction.
Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.